Ignite Creation Date:
2024-05-06 @ 7:33 PM
Last Modification Date:
2024-10-26 @ 3:09 PM
Study NCT ID:
NCT06053112
Status:
RECRUITING
Last Update Posted:
2024-04-17
First Post:
2023-06-26
Brief Title:
The Trial of a New Infant Formula in Healthy Term Chinese Infants
Sponsor:
Junlebao Dairy Group Co Ltd
Organization:
Junlebao Dairy Group Co Ltd
Study Overview
Official Title:
Safety and Efficacy of Infant Formula Containing a Specific Blend of Six Human Milk Oligosaccharides A Double-blind Randomized Controlled Trial
Status:
RECRUITING
Status Verified Date:
2024-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
HexaHMO
Brief Summary:
The aim of this randomized controlled multi-center double-blind study of healthy term infants is to test the safety and efficacy of a new infant formula with a specific blend of six human milk oligosaccharides The primary objective of the trial is to demonstrate the safety of the new infant formula supplemented by comparing the growth of infants randomized to the experimental formula versus the control formula from enrollment to the age of 4 months
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None